Clinical Trials in Boston

Showing 4321-4340 of 17,836 trials

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

NCT04434040

The purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: * Sacituzumab govitecan * Atezolizumab

Breast CancerTriple Negative Breast CancerResidual Cancer+1 more

Dana-Farber Cancer Institute40 participantsStarted Jul 2020

San Francisco, California, United States • Chicago, Illinois, United States • New Lenox, Illinois, United States +4 more locations

Active Not Recruiting< 1 mile

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

NCT03738774

This study will assess the relationship between early unmet needs after hospital discharge and subsequent clinical outcomes among survivors of acute respiratory failure. The investigators hypothesize that early unmet needs are associated with poor outcomes at three months.

Post Intensive Care Syndrome

Vanderbilt University Medical Center200 participantsStarted Jan 2019

Baltimore, Maryland, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +2 more locations

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Find Trials by Condition in Boston

PRIMARY Ancillary Substudy

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care

Registry and Natural History of Epilepsy-Dyskinesia Syndromes

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Doxazosin an a1 Antagonist for Alcohol Dependence

Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

A Study of ADRX-0706 in Select Advanced Solid Tumors

A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)